STRATA Skin Sciences, Inc. (SSKN)
USD 3.0
(-1.64%)
USD 3.0
(-1.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -519 Thousand | -1.1 Million | 1.5 Million | 2.09 Million | 2.22 Million | 2.89 Million |
| Net Income | -10.83 Million | -5.54 Million | -2.7 Million | -4.41 Million | -3.79 Million | -4.03 Million |
| Depreciation & Amortization | 5.9 Million | 5.68 Million | 4.08 Million | 3.91 Million | 4.82 Million | 5.39 Million |
| Deferred income taxes | -120 Thousand | 40 Thousand | 12 Thousand | 254 Thousand | -111 Thousand | -303 Thousand |
| Stock-based compensation | 1.3 Million | 1.46 Million | 1.64 Million | 1.63 Million | 1.19 Million | 904 Thousand |
| Change in working capital | -69 Thousand | -3.06 Million | 324 Thousand | 596 Thousand | -133 Thousand | 214 Thousand |
| Other non-cash items | 3.29 Million | 316 Thousand | -1.85 Million | 114 Thousand | 247 Thousand | 717 Thousand |
| Investing Cash Flow | -5.01 Million | -4.18 Million | -7.12 Million | -2.15 Million | -2.79 Million | -1.78 Million |
| Investments in PPE | -5.01 Million | -3.55 Million | -3.65 Million | -2.15 Million | -2.79 Million | -1.76 Million |
| Acquisitions | - | -631 Thousand | -3.47 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -631 Thousand | -3.47 Million | -2.13 Million | -2.67 Million | -23 Thousand |
| Financing Cash Flow | 6.86 Million | -500 Thousand | 92 Thousand | 2.54 Million | -296 Thousand | 11.3 Million |
| Debt repayment | -6.9 Million | - | -7.77 Million | -2.52 Million | -7.57 Million | -3.35 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 18 Thousand | - | 17 Million |
| Other Financing Activities | -42 Thousand | -500 Thousand | 7.86 Million | 5.05 Million | 7.27 Million | -2.33 Million |
| Accounts receivables | 141 Thousand | -1.14 Million | -490 Thousand | 1.35 Million | -1.03 Million | -222 Thousand |
| Accounts payables | -100 Thousand | 603 Thousand | 58 Thousand | 884 Thousand | 116 Thousand | -513 Thousand |
| Inventory | 689 Thousand | -1.52 Million | -45 Thousand | -417 Thousand | -233 Thousand | 215 Thousand |
| Other working capital | -799 Thousand | -1 Million | 801 Thousand | -1.22 Million | 1.02 Million | 734 Thousand |
| Cash at beginning of period | 6.79 Million | 12.58 Million | 18.11 Million | 15.62 Million | 16.48 Million | 4.06 Million |
| Cash at end of period | 8.11 Million | 6.79 Million | 12.58 Million | 18.11 Million | 15.62 Million | 16.48 Million |
| Capital Expenditure | -5.01 Million | -3.55 Million | -3.65 Million | -2.15 Million | -2.79 Million | -1.76 Million |
| Effect of forex changes on cash | -6.86 Million | - | - | - | - | - |
| Net cash flow / Change in cash | 1.32 Million | -5.79 Million | -5.52 Million | 2.48 Million | -858 Thousand | 12.41 Million |
| Free Cash Flow | -5.53 Million | -4.66 Million | -2.14 Million | -63 Thousand | -562 Thousand | 1.13 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -99 Thousand | -3.36 Million | -3.79 Million | -10.83 Million | -1.05 Million | -3.14 Million |
| Depreciation & Amortization | 1.32 Million | 1.34 Million | 1.37 Million | 5.9 Million | 1.53 Million | 1.49 Million |
| Deferred income taxes | - | - | -120 Thousand | -120 Thousand | -36 Thousand | 890 Thousand |
| Stock-based compensation | 163 Thousand | 112 Thousand | 289 Thousand | 1.3 Million | 337 Thousand | 352 Thousand |
| Change in working capital | -793 Thousand | 839 Thousand | 1.33 Million | -69 Thousand | -1.81 Million | 548 Thousand |
| Other non-cash items | 3.67 Million | 2.23 Million | 2.42 Million | 3.29 Million | 29 Thousand | 42 Thousand |
| Investing Cash Flow | -345 Thousand | -725 Thousand | -1.85 Million | -5.01 Million | -829 Thousand | -931 Thousand |
| Investments in PPE | -345 Thousand | -725 Thousand | -1.85 Million | -5.01 Million | -829 Thousand | -931 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | -18 Thousand | -6.86 Million | 6.86 Million | -104 Thousand | 6.96 Million |
| Debt repayment | - | - | -7.09 Million | -6.9 Million | -97 Thousand | -7 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -18 Thousand | 236 Thousand | -42 Thousand | -7000.00 | 13.96 Million |
| Accounts receivables | -295 Thousand | 726 Thousand | 267 Thousand | 141 Thousand | -334 Thousand | -418 Thousand |
| Accounts payables | -727 Thousand | 261 Thousand | 168 Thousand | -100 Thousand | -619 Thousand | 677 Thousand |
| Inventory | 160 Thousand | -154 Thousand | 1.03 Million | 689 Thousand | -72 Thousand | -169 Thousand |
| Other working capital | 69 Thousand | 6000.00 | -131.99 Thousand | -799 Thousand | -787 Thousand | 458 Thousand |
| Cash at beginning of period | 6.57 Million | 8.11 Million | 8.46 Million | 6.79 Million | 10.39 Million | 4.18 Million |
| Cash at end of period | 6.81 Million | 6.57 Million | 8.11 Million | 8.11 Million | 8.46 Million | 10.39 Million |
| Capital Expenditure | -345 Thousand | -725 Thousand | -1.85 Million | -5.01 Million | -829 Thousand | -931 Thousand |
| Effect of forex changes on cash | - | - | -2.75 Million | -6.86 Million | 2.75 Million | - |
| Net cash flow / Change in cash | 246 Thousand | -1.54 Million | -347 Thousand | 1.32 Million | -1.93 Million | 6.2 Million |
| Free Cash Flow | 246 Thousand | -1.52 Million | -347 Thousand | -5.53 Million | -1.82 Million | -756 Thousand |
CWT
002654
200468
600587
ATSG
SYG